I’ve been following MCRB for 5 years. Bought a big postion @ $5.00, once the company announced the beginning of the phase III trial. I’ve not see any strong support here for MCRB, but I sure am glad I hung in there for the big announcement of a successful phase III trial. Stock rocketed up after the announcementon Mon to $33, and has now settled down to ~$27. I have limited knowledge re what to plan for now: sell or hold through the uphill FDA slog? Any thoughts?
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.